Colgate-Palmolive Company $CL Shares Newly Purchased by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 355,892 shares of the company’s stock, valued at approximately $30,365,000.

A number of other institutional investors also recently bought and sold shares of the company. Cooper Financial Group grew its stake in shares of Colgate-Palmolive by 4.0% in the 2nd quarter. Cooper Financial Group now owns 2,947 shares of the company’s stock valued at $270,000 after buying an additional 114 shares during the period. Gould Capital LLC increased its holdings in shares of Colgate-Palmolive by 38.7% during the 1st quarter. Gould Capital LLC now owns 412 shares of the company’s stock worth $35,000 after buying an additional 115 shares during the last quarter. Redhawk Wealth Advisors Inc. raised its position in shares of Colgate-Palmolive by 2.8% during the 2nd quarter. Redhawk Wealth Advisors Inc. now owns 4,326 shares of the company’s stock valued at $397,000 after buying an additional 118 shares during the period. SVB Wealth LLC raised its position in shares of Colgate-Palmolive by 1.4% during the 2nd quarter. SVB Wealth LLC now owns 8,767 shares of the company’s stock valued at $804,000 after buying an additional 119 shares during the period. Finally, Sowell Financial Services LLC lifted its holdings in Colgate-Palmolive by 2.1% in the third quarter. Sowell Financial Services LLC now owns 5,737 shares of the company’s stock valued at $490,000 after acquiring an additional 119 shares during the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

CL has been the subject of several analyst reports. Wells Fargo & Company increased their price objective on Colgate-Palmolive from $90.00 to $95.00 and gave the stock an “equal weight” rating in a research report on Monday. JPMorgan Chase & Co. reduced their target price on Colgate-Palmolive from $104.00 to $102.00 and set an “overweight” rating on the stock in a research report on Monday. Royal Bank Of Canada lifted their target price on Colgate-Palmolive from $104.00 to $105.00 and gave the company an “outperform” rating in a research report on Monday. TD Cowen upped their price target on Colgate-Palmolive from $90.00 to $97.00 and gave the company a “hold” rating in a research note on Monday. Finally, Jefferies Financial Group reiterated a “hold” rating and set a $89.00 price target (up from $88.00) on shares of Colgate-Palmolive in a report on Monday, August 3rd. Thirteen analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average target price of $100.78.

View Our Latest Report on CL

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $97.59 on Tuesday. The company’s 50 day simple moving average is $89.67 and its 200-day simple moving average is $89.72. The company has a market capitalization of $77.79 billion, a price-to-earnings ratio of 38.27, a price-to-earnings-growth ratio of 4.44 and a beta of 0.33. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $99.33. The company has a debt-to-equity ratio of 13.82, a quick ratio of 0.67 and a current ratio of 1.03.

Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings data on Friday, October 30th. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.93 by $0.04. The firm had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.34 billion. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the prior year, the business posted $0.91 EPS. As a group, equities research analysts expect that Colgate-Palmolive Company will post 3.89 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be given a $0.53 dividend. The ex-dividend date of this dividend is Tuesday, October 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.2%. Colgate-Palmolive’s payout ratio is presently 84.13%.

Colgate-Palmolive News Summary

Here are the key news stories impacting Colgate-Palmolive this week:

  • Positive Sentiment: Colgate-Palmolive reported third-quarter sales growth of 4.6%, exceeded earnings expectations, narrowed its full-year sales outlook, and raised its margin and EPS guidance. The results suggest pricing, productivity efforts, and steady demand are offsetting inflationary and operating-cost pressures. Colgate-Palmolive sales rise 4.6% and it lifts margin and EPS outlook
  • Positive Sentiment: Management highlighted resilient global demand and premium product innovation, supporting expectations for continued organic growth despite a challenging cost environment. CL Q3 deep dive: global demand and premium innovation support steady growth amid cost pressures
  • Positive Sentiment: Morgan Stanley raised its price target to $111 from $104 and maintained an Overweight rating. BNP Paribas Exane also lifted its target to $108 from $97 while reaffirming Outperform, reflecting greater confidence after the quarterly beat. Colgate-Palmolive Analysts Boost Their Forecasts After Upbeat Q3 Earnings
  • Positive Sentiment: Royal Bank of Canada raised its target to $105 from $104 and retained an Outperform rating, while Wells Fargo increased its target to $95 from $90. The broad target revisions indicate improved earnings expectations, even though analyst conviction varies.
  • Neutral Sentiment: JPMorgan lowered its target modestly to $102 from $104 but kept an Overweight rating. Barclays likewise maintained a Hold rating, signaling that some analysts view the recent rally and valuation as largely reflecting the improved outlook.
  • Neutral Sentiment: Colgate-Palmolive appointed Akash Parekh to lead India marketing following Gunjit Jain’s departure. The leadership transition could affect execution in an important growth market, but no immediate financial impact was reported. Colgate-Palmolive Picks Akash Parekh To Lead India Marketing
  • Negative Sentiment: Investors continue to monitor margin pressure and lingering questions about profit growth. Wells Fargo’s Equal Weight rating and target below the recent trading level underscore concerns that cost inflation and a relatively full valuation could limit further upside.

Insiders Place Their Bets

In other news, COO Panagiotis Tsourapas sold 10,000 shares of Colgate-Palmolive stock in a transaction on Monday, August 24th. The stock was sold at an average price of $92.05, for a total value of $920,500.00. Following the completion of the sale, the chief operating officer directly owned 64,901 shares of the company’s stock, valued at approximately $5,974,137.05. The trade was a 13.35% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director John T. Cahill sold 4,170 shares of the business’s stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $93.37, for a total value of $389,352.90. Following the completion of the sale, the director owned 28,373 shares in the company, valued at $2,649,187.01. This represents a 12.81% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.43% of the stock is owned by corporate insiders.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill’s Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill’s Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.

See Also

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.